Magnetic iron oxide nanoparticles: synthesis, characterization and functionalization for biomedical applications in the central nervous system SAMK Ansari, E Ficiarà, FA Ruffinatti, I Stura, M Argenziano, O Abollino, ... Materials 12 (3), 465, 2019 | 227 | 2019 |
Design and optimization of self-microemulsifying drug delivery system (SMEDDS) of felodipine for chronotherapeutic application KA Ansari, KP Pagar, S Anwar, PR Vavia Brazilian Journal of Pharmaceutical Sciences 50 (1), 203-212, 2014 | 30 | 2014 |
Superparamagnetic oxygen-loaded nanobubbles to enhance tumor oxygenation during hyperthermia S Zullino, M Argenziano, S Ansari, R Ciprian, L Nasi, F Albertini, R Cavalli, ... Frontiers in Pharmacology 10, 1001, 2019 | 24 | 2019 |
A phase I dose escalation study of oxaliplatin, cisplatin and doxorubicin applied as PIPAC in patients with peritoneal carcinomatosis M Robella, M De Simone, P Berchialla, M Argenziano, A Borsano, ... Cancers 13 (5), 1060, 2021 | 23 | 2021 |
Beyond oncological hyperthermia: physically drivable magnetic nanobubbles as novel multipurpose theranostic carriers in the central nervous system E Ficiarà, SA Ansari, M Argenziano, L Cangemi, C Monge, R Cavalli, ... Molecules 25 (9), 2104, 2020 | 21 | 2020 |
Machine Learning Profiling of Alzheimer's Disease Patients Based on Current Cerebrospinal Fluid Markers and Iron Content in Biofluids E Ficiarà, S Boschi, S Ansari, F D'Agata, O Abollino, P Caroppo, ... Frontiers in Aging Neuroscience 13, 607858, 2021 | 20 | 2021 |
Magnetic iron oxide nanoparticles: synthesis, characterization and functionalization for biomedical applications in the central nervous system, Materials 12 (2019) 465 S Ansari, E Ficiarà, FA Ruffinatti, I Stura, M Argenziano, O Abollino, ... | 7 | 2019 |
Magnetic iron oxide nanoparticles: synthesis, characterization and functionalization for biomedical applications in the central nervous system. Materials (Basel) 12: 465 S Ansari, E Ficiarà, FA Ruffinatti, I Stura, M Argenziano, O Abollino, ... | 7 | 2019 |
Magnetic iron oxide nanoparticles: synthesis, characterization and functionalization for biomedical applications in the central nervous system. Materials (Basel) 2019; 12: 465 S Ansari, E Ficiarà, FA Ruffinatti, I Stura, M Argenziano, O Abollino, ... | 7 | |
A Phase I Dose Escalation Study of Oxaliplatin, Cisplatin and Doxorubicin Applied as PIPAC in Patients with Peritoneal Carcinomatosis. Cancers 2021, 13, 1060 M Robella, M De Simone, P Berchialla, M Argenziano, A Borsano, ... doi. org/10.3390/cancers13051060, 2021 | 5 | 2021 |
CNT-based nano medicine from synthesis to therapeutic application SY Ansari, SA Ansari, F Alshammari, S Anwar Innovative Approaches for Nanobiotechnology in Healthcare Systems, 175-211, 2022 | 3 | 2022 |
Quercetin and Kaempferol as Multi-Targeting Antidiabetic Agents against Mouse Model of Chemically Induced Type 2 Diabetes M Ali, M Hassan, SA Ansari, HM Alkahtani, LS Al-Rasheed, SA Ansari Pharmaceuticals 17 (6), 757, 2024 | 1 | 2024 |
Developing Iron Nanochelating Agents: Preliminary Investigation of Effectiveness and Safety for Central Nervous System Applications E Ficiarà, C Molinar, S Gazzin, S Jayanti, M Argenziano, L Nasi, F Casoli, ... International Journal of Molecular Sciences 25 (2), 729, 2024 | 1 | 2024 |
Step-by-Step Design of New Theranostic Nanoformulations: Multifunctional Nanovectors for Radio-Chemo-Hyperthermic Therapy under Physical Targeting SA Ansari, E Ficiarà, F D’Agata, R Cavalli, L Nasi, F Casoli, F Albertini, ... Molecules 26 (15), 4591, 2021 | 1 | 2021 |
From Synthesis to Therapeutic Application S Anwar | | 2022 |
Potential therapeutic use of magnetic nanocarriers in brain tumors E Ficiarà, S Ansari, F D'Agata, M Argenziano, R Cavalli, C Guiot IL NUOVO CIMENTO C 44 (4-5 art. no. 131), 1-4, 2021 | | 2021 |
A physical approach to AD Pathogenesis and treatment FDA Caterina Guiot, Eleonora Ficiarà, Shoeb Ansari, Silvia Boschi Journal of Brain and Neurology 2 (Issue 1), 2019 | | 2019 |
PERFORMANCE ANALYSIS OF JUNCTIONLESS SONOS MEMORY SA Ansari, D Rao, R Mohan | | 2016 |